{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:02:31Z","timestamp":1793325751486,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T00:00:00Z","timestamp":1382659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2369-14-233","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T18:35:19Z","timestamp":1382726119000},"source":"Crossref","is-referenced-by-count":17,"title":["TNF-\u03b1 blockade is ineffective in animal models of established polycystic kidney disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Jeffrey","family":"Roix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,10,25]]},"reference":[{"issue":"14","key":"657_CR1","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMcp0804458","volume":"359","author":"JJ Grantham","year":"2008","unstructured":"Grantham JJ: Clinical practice Autosomal dominant polycystic kidney disease. N Engl J Med. 2008, 359 (14): 1477-1485. 10.1056\/NEJMcp0804458.","journal-title":"N Engl J Med"},{"issue":"2","key":"657_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cell.2004.07.007","volume":"118","author":"P Delmas","year":"2004","unstructured":"Delmas P: Polycystins: from mechanosensation to gene regulation. Cell. 2004, 118 (2): 145-148. 10.1016\/j.cell.2004.07.007.","journal-title":"Cell"},{"issue":"5","key":"657_CR3","doi-asserted-by":"publisher","first-page":"F1423","DOI":"10.1152\/ajprenal.00275.2007","volume":"293","author":"T Weimbs","year":"2007","unstructured":"Weimbs T: Polycystic kidney disease and renal injury repair: common pathways, fluid flow, and the function of polycystin-1. Am J Physiol Renal Physiol. 2007, 293 (5): F1423-F1432. 10.1152\/ajprenal.00275.2007.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"657_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1681\/ASN.2004121090","volume":"16","author":"X Wang","year":"2005","unstructured":"Wang X, Gattone V, Harris PC, Torres VE: Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol. 2005, 16 (4): 846-851. 10.1681\/ASN.2004121090.","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"657_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/ndt\/gfi181","volume":"21","author":"PR Wahl","year":"2006","unstructured":"Wahl PR, Serra AL, Le Hir M, Molle KD, Hall MN, W\u00fcthrich RP: Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant. 2006, 21 (3): 598-604. 10.1093\/ndt\/gfi181.","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"657_CR6","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1093\/ndt\/gfr069","volume":"26","author":"E Meijer","year":"2011","unstructured":"Meijer E, Gansevoort RT, de Jong PE, et al: Therapeutic potential of vasopressin V2 receptor antagonist in a mouse model for autosomal dominant polycystic kidney disease: optimal timing and dosing of the drug. Nephrol Dial Transplant. 2011, 26 (8): 2445-2453. 10.1093\/ndt\/gfr069.","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"657_CR7","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1056\/NEJMe1006925","volume":"363","author":"T Watnick","year":"2010","unstructured":"Watnick T, Germino GG: mTOR inhibitors in polycystic kidney disease. N Engl J Med. 2010, 363 (9): 879-881. 10.1056\/NEJMe1006925.","journal-title":"N Engl J Med"},{"issue":"6","key":"657_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1681\/ASN.2010030262","volume":"21","author":"RW Schrier","year":"2010","unstructured":"Schrier RW: Randomized intervention studies in human polycystic kidney and liver disease. J Am Soc Nephrol. 2010, 21 (6): 891-893. 10.1681\/ASN.2010030262.","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"657_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1056\/NEJMoa0907419","volume":"363","author":"AL Serra","year":"2010","unstructured":"Serra AL, Poster D, Kistler AD, et al: Sirolimus and kidney growth in autosomal dominant polycystic kidney disease. N Engl J Med. 2010, 363 (9): 820-829. 10.1056\/NEJMoa0907419.","journal-title":"N Engl J Med"},{"issue":"7","key":"657_CR10","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1056\/NEJMct055183","volume":"355","author":"DL Scott","year":"2006","unstructured":"Scott DL, Kingsley GH: Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med. 2006, 355 (7): 704-712. 10.1056\/NEJMct055183.","journal-title":"N Engl J Med"},{"issue":"18","key":"657_CR11","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMra1102942","volume":"365","author":"S Danese","year":"2011","unstructured":"Danese S, Fiocchi C: Ulcerative colitis. N Engl J Med. 2011, 365 (18): 1713-1725. 10.1056\/NEJMra1102942.","journal-title":"N Engl J Med"},{"issue":"8","key":"657_CR12","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nm1783","volume":"14","author":"X Li","year":"2008","unstructured":"Li X, Magenheimer BS, Xia S, et al: A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat Med. 2008, 14 (8): 863-868. 10.1038\/nm1783.","journal-title":"Nat Med"},{"issue":"1","key":"657_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A, et al: Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009, 20 (1): 205-212. 10.1681\/ASN.2008050507.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"657_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1538\/expanim.49.51","volume":"49","author":"M Katsuyama","year":"2000","unstructured":"Katsuyama M, Masuyama T, Komura I, Hibino T, Takahashi H: Characterization of a novel polycystic kidney rat model with accompanying polycystic liver. Exp Anim. 2000, 49 (1): 51-55. 10.1538\/expanim.49.51.","journal-title":"Exp Anim"},{"issue":"1","key":"657_CR15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/ndt\/gfq384","volume":"26","author":"C Renken","year":"2011","unstructured":"Renken C, Fischer DC, Kundt G, Gretz N, Haffner D: Inhibition of mTOR with sirolimus does not attenuate progression of liver and kidney disease in PCK rats. Nephrol Dial Transplant. 2011, 26 (1): 92-100. 10.1093\/ndt\/gfq384.","journal-title":"Nephrol Dial Transplant"},{"issue":"5573","key":"657_CR16","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1126\/science.1071924","volume":"296","author":"G Chen","year":"2002","unstructured":"Chen G, Goeddel DV: TNF-R1 signaling: a beautiful pathway. Science. 2002, 296 (5573): 1634-1635. 10.1126\/science.1071924.","journal-title":"Science"},{"issue":"2","key":"657_CR17","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","volume":"93","author":"G Wu","year":"1998","unstructured":"Wu G, D\u2019Agati V, Cai Y, et al: Somatic inactivation of Pkd2 results in polycystic kidney disease. Cell. 1998, 93 (2): 177-188. 10.1016\/S0092-8674(00)81570-6.","journal-title":"Cell"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-233\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-233","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T04:10:32Z","timestamp":1548216632000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,25]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["657"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-233","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,25]]},"article-number":"233"}}